Clinical Trials Logo

Clinical Trial Summary

The purpose of this 12-month, prospective, multicenter study is to investigate the effect of annular defect size and other risk factors on reherniation and associated costs in primary lumbar discectomy patients.


Clinical Trial Description

This study will enroll up to 100 patients at select US (approximately 4-7) sites. Patients that are scheduled for an L1-S1 discectomy and who meet the pre-operative eligibility criteria will be considered for study participation. Patients will be divided into two arms (small- and large-defect) based on the size of their annular defect as measured intra-operatively; each arm will be capped at 50 patients. All patients included in the trial will be followed for at least 12 months. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02477176
Study type Observational
Source Intrinsic Therapeutics
Contact
Status Active, not recruiting
Phase
Start date February 17, 2016
Completion date March 2025

See also
  Status Clinical Trial Phase
Completed NCT02454400 - Pre-surgery Physiotherapy for Patients With Specific Low Back Pain N/A
Terminated NCT01397552 - Dexamethasone Versus Depo Medrol in Lumbar Epidurals N/A
Completed NCT01843296 - Effects of Addition of Magnesium Sulfate in Spinal Anesthesia on Sensory-Motor Blocks and Postoperative Pain in Lumbar Disk Herniation Surgery Phase 4
Terminated NCT02026726 - Do Oral Steroid Dose Packs Predict How Well Epidural Steroid Injections Will Work?
Completed NCT01335646 - Surgery Versus Standardized Non-operative Care for the Treatment of Lumbar Disc Herniations: A Canadian Trial N/A
Recruiting NCT01640431 - Lumbar Segmental Stabilization and TENS in Lumbar Disc Herniation N/A
Terminated NCT01429363 - Targeted Disc Decompression (TDD) for Contained Herniated Lumbar Discs N/A